Whitney Johnson
Psychiatric/Mental Health · Gosnell, ARNPI 1780966127
Payments from drug & device makers
Across 112 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$367
- AbbVie$288
- Otsuka America Pharmaceutical, Inc.$276
- Johnson & Johnson$258
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$130
- Indivior Inc.$113
- plus $329 from 6 others
What the payments were for
- Food & beverage$1,755100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 15 | $367 |
| AbbVie | 17 | $288 |
| Otsuka America Pharmaceutical, Inc. | 19 | $276 |
| Johnson & Johnson | 19 | $258 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $130 |
| Indivior Inc. | 7 | $113 |
| Sunovion Pharmaceuticals Inc. | 13 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Genentech USA, Inc. | 5 | $43 |
| Lundbeck LLC | 2 | $33 |
| Neurocrine Biosciences, Inc. | 2 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
How this compares
$1,761 in reported general payments places this provider in the 65th percentile of 359 psychiatric/mental health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxcarbazepine | 16 | $493 |
| Aripiprazole | 28 | $384 |
| Doxepin Hcl | 16 | $377 |
| Quetiapine Fumarate | 30 | $332 |
| Buspirone Hcl | 26 | $301 |
| Duloxetine Hcl | 22 | $277 |
| Escitalopram Oxalate | 22 | $201 |
| Paroxetine Hcl | 19 | $197 |
| Sertraline Hcl | 35 | $175 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $162 |
| Amitriptyline Hcl | 14 | $147 |
| Hydroxyzine Pamoate | 13 | $114 |
| Fluoxetine Hcl | 28 | $91 |
| Trazodone Hcl | 22 | $82 |
| Alprazolam | 17 | $75 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Gosnell
- Christie KellerFayetteville$167K
- Stephanie BohannonFayetteville$32K
- Michael BelinSherwood$30K
- Sarah RamseySearcy$12K
- Mallori LevengoodPine Bluff$11K
- Jennifer PenneFayetteville$11K
- Stephanie ParishSearcy$9K
- Elizabeth HardyTexarkana$8K
- Tammy HawkinsJonesboro$8K
- Cara MeckfesselLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.